Cross-Sectional Survey of Smoking Patterns During the COVID-19 Pandemic in a Tobacco Cessation and Lung Cancer Screening Program

REFERENCES

1. 1.↵
   1. Creamer MR,
   2. Wang TW,
   3. Babb S,
   4. et al.

   Tobacco product use and cessation indicators among adults – United States, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(45):1013-1019. doi: 10.15585/mmwr.mm6845a2

   OpenUrlCrossRefPubMed
2. 2.↵
   COVID Data Tracker. Centers for Disease Control and Prevention. Accessed February 28, 2022. covid.cdc.gov/covid-data-tracker
3. 3.↵
   1. Caponnetto P,
   2. Inguscio L,
   3. Saitta C,
   4. Maglia M,
   5. Benfatto F,
   6. Polosa R

   . Smoking behavior and psychological dynamics during COVID-19 social distancing and stay-at-home policies: a survey. Health Psychol Res. 2020;8(1):9124. doi: 10.4081/hpr.2020.9124

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Van Haren RM,
   2. Delman AM,
   3. Turner KM,
   4. et al.

   Impact of the COVID-19 pandemic on lung cancer screening program and subsequent lung cancer. J Am Coll Surg. 2021;232(4):600-605. doi: 10.1016/j.jamcollsurg.2020.12.002

   OpenUrlCrossRef
5. 5.↵
   1. Kaufman HW,
   2. Chen Z,
   3. Niles J,
   4. Fesko Y

   . Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw Open. 2020;3(8):e2017267. doi: 10.1001/jamanetworkopen.2020.17267. Erratum in: JAMA Netw Open. 2020;3(9):e2020927. doi: 10.1001/jamanetworkopen.2020.20927

   OpenUrlCrossRef
6. 6.↵
   1. Chavez-MacGregor M,
   2. Lei X,
   3. Zhao H,
   4. Scheet P,
   5. Giordano SH

   . Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer. JAMA Oncol. 2022;8(1):69-78. doi: 10.1001/jamaoncol.2021.5148

   OpenUrlCrossRef
7. 7.↵
   1. Jaklevic MC

   . COVID-19 and the “lost year” for smokers trying to quit. JAMA. 2021;325(19):1929-1930. doi: 10.1001/jama.2021.5601

   OpenUrlCrossRef
8. 8.↵
   1. Blackmon SH,
   2. Feinglass SR

   . The United States Preventive Services Task Force recommendations for lung cancer screening. Thorac Surg Clin. 2015;25(2):199-203. doi: 10.1016/j.thorsurg.2014.12.004

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Leeman J,
   2. Birken SA,
   3. Powell BJ,
   4. Rohweder C,
   5. Shea CM

   . Beyond “implementation strategies”: classifying the full range of strategies used in implementation science and practice. Implement Sci. 2017;12(1):125. doi: 10.1186/s13012-017-0657-x

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Vandenbroucke JP,
    2. von Elm E,
    3. Altman DG,
    4. et al.

    Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147(8):W163-W194. doi: 10.7326/0003-4819-147-8-200710160-00010-w1

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Merikangas K,
    2. Milham M,
    3. Stringaris A,
    4. Bromet E,
    5. Colcombe S,
    6. Zipunnikov V

    . The Coronovirus Health Impact Survey (CRISIS). Accessed February 18, 2022. www.crisissurvey.org/
12. 12.↵
    COVID-19 Guidance Documents. Centers for Disease and Control Prevention. Accessed April 30, 2020. www.cdc.gov/coronavirus/2019-ncov/communication/guidance-list.html?Sort=Date%3A%3Adesc&Audience=General%20Public&Topic=Prevention%20%26%20Infection%20Control
13. 13.↵
    1. Bommele J,
    2. Hopman P,
    3. Walters BH,
    4. et al.

    The double-edged relationship between COVID-19 stress and smoking: implications for smoking cessation. Tob Induc Dis. 2020;18:63. doi: 10.18332/tid/125580

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Klemperer EM,
    2. West JC,
    3. Peasley-Miklus C,
    4. Villanti AC

    . Change in tobacco and electronic cigarette use and motivation to quit in response to COVID-19. Nicotine Tob Res. 2020;22(9):1662-1663. doi: 10.1093/ntr/ntaa072

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Stanton R,
    2. To QG,
    3. Khalesi S,
    4. et al.

    Depression, anxiety and stress during COVID-19: associations with changes in physical activity, sleep, tobacco and alcohol use in Australian adults. Int J Environ Res Public Health. 2020;17(11):4065. doi: 10.3390/ijerph17114065

    OpenUrlCrossRef
16. 16.↵
    1. Constant A,
    2. Conserve DF,
    3. Gallopel-Morvan K,
    4. Raude J

    . Socio-cognitive factors associated with lifestyle changes in response to the COVID-19 epidemic in the general population: results from a cross-sectional study in France. Front Psychol. 2020;11:579460. doi: 10.3389/fpsyg.2020.579460

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Cancello R,
    2. Soranna D,
    3. Zambra G,
    4. Zambon A,
    5. Invitti C

    . Determinants of the lifestyle changes during COVID-19 pandemic in the residents of northern Italy. Int J Environ Res Public Health. 2020;17(17):6287. doi: 10.3390/ijerph17176287

    OpenUrlCrossRef
18. 18.↵
    1. Sidor A,
    2. Rzymski P

    . Dietary choices and habits during COVID-19 lockdown: experience from Poland. Nutrients. 2020;12(6):1657. doi: 10.3390/nu12061657

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Lang AE,
    2. Yakhkind A

    . Coronavirus disease 2019 and smoking: how and why we implemented a tobacco treatment campaign. Chest. 2020;158(4):1770-1776. doi: 10.1016/j.chest.2020.06.013

    OpenUrlCrossRef
20. 20.↵
    1. Pettigrew S,
    2. Jun M,
    3. Roberts I,
    4. Bullen C,
    5. Nallaiah K,
    6. Rodgers A

    . Preferences for tobacco cessation information and support during Covid-19. J Addict Med. 2020;14(6):e362-e365. doi: 10.1097/ADM.0000000000000743

    OpenUrlCrossRef
21. 21.↵
    1. Hennekens CH,
    2. DeMets D

    . Statistical association and causation: contributions of different types of evidence. JAMA. 2011;305(11):1134-1136. doi: 10.1001/jama.2011.322

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Hennekens CH,
    2. Buring JE

    . Epidemiology in Medicine. Little, Brown and Company; 1987.